PetIQ, Inc. (NASDAQ:PETQ) has been assigned an average recommendation of “Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $27.00.

PETQ has been the topic of several research analyst reports. CIBC initiated coverage on PetIQ in a research report on Tuesday, August 15th. They set an “outperform” rating and a $28.00 target price on the stock. Jefferies Group LLC started coverage on PetIQ in a research note on Tuesday, August 15th. They set a “hold” rating and a $25.00 price target on the stock. SunTrust Banks, Inc. started coverage on PetIQ in a research note on Tuesday, August 15th. They set a “buy” rating and a $28.00 price target on the stock. Raymond James Financial, Inc. started coverage on PetIQ in a research note on Tuesday, August 15th. They set an “outperform” rating and a $26.00 price target on the stock. Finally, William Blair started coverage on PetIQ in a research note on Tuesday, August 15th. They set an “outperform” rating on the stock.

Several hedge funds have recently made changes to their positions in PETQ. Essex Investment Management Co. LLC purchased a new stake in shares of PetIQ in the third quarter valued at approximately $2,162,000. Emerald Advisers Inc. PA purchased a new stake in shares of PetIQ in the third quarter valued at approximately $2,498,000. Emerald Mutual Fund Advisers Trust purchased a new stake in shares of PetIQ in the third quarter valued at approximately $1,856,000. Finally, Monarch Partners Asset Management LLC purchased a new stake in shares of PetIQ in the third quarter valued at approximately $1,892,000. Institutional investors own 0.70% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Brokerages Set PetIQ, Inc. (PETQ) Target Price at $27.00” was first reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://theolympiareport.com/2017/11/01/brokerages-set-petiq-inc-petq-target-price-at-27-00.html.

About PetIQ

PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.

Analyst Recommendations for PetIQ (NASDAQ:PETQ)

Receive News & Ratings for PetIQ Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.